Bildkälla: Stockfoto

Optomed: Decreased full-year outlook - Redeye

Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease compared to 2023. We do not place too much weight on the updated outlook; however, we make some changes to our revenue estimates, rendering an updated fair value range.

Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease compared to 2023. We do not place too much weight on the updated outlook; however, we make some changes to our revenue estimates, rendering an updated fair value range.
Börsvärldens nyhetsbrev
ANNONSER